AstraZeneca plc (AZN) stock has risen 31.42% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AZN stock a score of 86 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 97. AZN's rank also includes a long-term technical score of 90. The fundamental score for AZN is 71. In addition to the average rating from Wall Street analysts, AZN stock has a mean target price of 58.525. This means analysts expect the stock to increase 11.39% over the next 12 months.
What's Happening with AZN Stock Today
AstraZeneca plc (AZN) stock has risen 2.12% while the S&P 500 has fallen -0.05% as of 1:06 PM on Monday, Jun 15. AZN has risen $1.09 from the previous closing price of $51.45 on volume of 3,933,708 shares. Over the past year the S&P 500 is up 5.20% while AZN has risen 31.42%. AZN earned $0.51 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 102.48.
Click Here to get the full Stock Score Report on AstraZeneca plc (AZN) Stock.
